Category: Therapeutic Area
Middle East Therapeutic Area
-
Vitreous Tamponades Market, By Product Type (Gases (Silicone Oil, PFCL), Liquid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Vitreous tamponades are essentials used in vitrectomy procedures for healing or reattachment of retina and in vitreous dysfunction. These are used majorly used in various retinal disorders such as retinal detachment, diabetic retinopathy, retinitis pigmentosa, ... Read More
-
MEA Age-Related Macular Degeneration (AMD) Disease Market - Industry Trends and Forecast to 2029
... of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029 Market Segmentation: Middle East and ... Read More
-
Middle East and Africa Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Artificial Tears, Antibiotic Drops, Hormone Drops, and Others) and Type (OTC Drugs and Prescription Drugs)
... dry eye products market in the MEA is expected to grow from US$ 212.83 million in 2021 to US$ 262.65 million by 2028; it is estimated to grow at a CAGR of 2.9% from 2021 ... Read More
-
Middle East and Africa Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Middle East and Africa pharmacogenomics market is expected to reach US$ 427.68 million by 2028 from US$ ... Read More
-
Benzodiazepine Drugs Market, by Product (Long Acting Benzodiazepine {Chlordiazepoxide, Diazepam, Lorazepam, Alprazolam, Clonazepam, and Others}, Short Acting Benzodiazepine {Temazepam, Midazolam, Triazolam and Others), by Application (Anxiety Disorders, Nervousness, Sedation, Seizures, Alcohol Withdrawal and Others), by Route of Administration (Oral, Injectables, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Route of Administration (Oral, Injectables, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, ... Read More
-
Middle East and Africa Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Middle East and Africa carbapenem-based antibiotics market is expected to reach US$ 297.20 million by 2028 from US$ 237.42 ... Read More
-
Middle East and Africa Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The Middle East & Africa non-invasive ventilation masks market is expected to reach US$ 114.0 million by 2028 from US$ 84.2 million in ... Read More
-
Middle East and Africa Concussion Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type {Treatment and Diagnosis [Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-Rays, and Others]} and End User (Hospital & Clinics, Diagnostic Centers, and Others)
... & Clinics, Diagnostic Centers, and Others) The Middle East & Africa concussion market is expected to reach US$ 380.0 million by 2028 from US$ 315.1 million in 2021. The market is estimated to grow at ... Read More
-
Middle East and Africa Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Middle East & Africa monoclonal antibodies market is expected to reach US$ 5,741.1 million by ... Read More
-
Middle East and Africa Retinal Imaging Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device Type (Fluorescein Angiography, Fundus Camera, and Optical Coherence Tomography), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Specialized Eye Care Centers, Other End Users)
... Specialized Eye Care Centers, Other End Users) The Middle East & Africa retinal imaging devices market is expected to reach US$ 166.7 million by 2028 from US$ 119.9 million in 2021. The market is estimated ... Read More
-
Middle East and Africa Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Botulinum toxin A and Botulinum toxin B), Application (Medical and Aesthetic), and End User (Speciality and Dermatology Clinics, Hospitals and Clinics, and Others)
... Dermatology Clinics, Hospitals and Clinics, and Others) The Middle East & Africa (MEA) botulinum toxin market is expected to reach US$ 288.2 million by 2028 from US$ 199.6 million in 2021. The market is estimated ... Read More
-
Latin America, Middle East & Africa Digestive Enzyme Supplements Market Databank
... CAGR of 3.95% from 2021 to 2029. Plant segment is expected to be the highest contributor to this market, with $20.3 Million in 2020, and is anticipated to reach $28.6 Million by 2029, registering a ... Read More
-
Latin America, Middle East & Africa Oncology Market Databank
... 2021 to 2029. Cancer treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. ... Read More
-
Latin America, Middle East & Africa Fertility Testing Devices Market Databank
... CAGR of 13.52% from 2021 to 2029. Ovulation Prediction Kits segment is expected to be the highest contributor to this market, with $216.4 Million in 2020, and is anticipated to reach $673.5 Million by 2029, ... Read More
-
Latin America, Middle East & Africa Egg Donation Market Databank
... 11.58% from 2021 to 2029. Frozen segment is expected to be the highest contributor to this market, with $1,303.6 Million in 2020, and is anticipated to reach $3,495.6 Million by 2029, registering a CAGR of ... Read More
-
Latin America, Middle East & Africa Wearable Breast Pumps Market Databank
... CAGR of 7.15% from 2021 to 2029. Accessories segment is expected to be the highest contributor to this market, with $284.9 Million in 2020, and is anticipated to reach $527.5 Million by 2029, registering a ... Read More
-
Latin America, Middle East & Africa Respiratory Protective Equipment Market Databank
... CAGR of 3.69% from 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, ... Read More
-
Latin America, Middle East & Africa Spectacle Market Databank
... 2021 to 2029. Offline segment is expected to be the highest contributor to this market, with $67,157.8 Million in 2020, and is anticipated to reach $133,811.2 Million by 2029, registering a CAGR of 8.01%. Online ... Read More
-
Latin America, Middle East & Africa Colposcopy Market Databank
... 2021 to 2029. Optical segment is expected to be the highest contributor to this market, with $100.3 Million in 2020, and is anticipated to reach $170.7 Million by 2029, registering a CAGR of 6.13%. Digital ... Read More
-
Latin America, Middle East & Africa Ophthalmic Ultrasound Devices Market Databank
... CAGR of 7.51% from 2021 to 2029. A-Scan segment is expected to be the highest contributor to this market, with $135,501.3 Million in 2020, and is anticipated to reach $261,140.9 Million by 2029, registering a ... Read More
-
Latin America, Middle East & Africa Digestive Health Products Market Databank
... CAGR of 3.06% from 2021 to 2029. Bakery & Cereals segment is expected to be the highest contributor to this market, with $650.5 Million in 2020, and is anticipated to reach $847.5 Million by 2029, ... Read More
-
Latin America, Middle East & Africa Laparoscopic Gynecological Procedures Market Databank
... CAGR of 16.75% from 2021 to 2029. Laparoscopic Hysterectomy segment is expected to be the highest contributor to this market, with $10,259.5 Million in 2020, and is anticipated to reach $32,379.2 Million by 2029, registering ... Read More
-
Latin America, Middle East & Africa Digestive Health Supplements Market Databank
... CAGR of 2.88% from 2021 to 2029. OTC segment is expected to be the highest contributor to this market, with $7,232.0 Million in 2020, and is anticipated to reach $9,376.0 Million by 2029, registering a ... Read More
-
Middle East and Asia Pacific Cell and Gene Therapy Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), by Technology (Lentiviral Vector, Plasmid DNA, and AAV), and by Region (Middle East and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
Research Assistance
